(Q68144292)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Efficacy and Safety of Lodoxamide 0.1% vs Cromolyn Sodium 4% in Patients with Vernal Keratoconjunctivitis (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)74786-5

13 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)74786-5

13 October 2022

author name string

D. R. Caldwell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1598953

13 October 2022

P. Verin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1598953

13 October 2022

R. Hartwich-Young

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1598953

13 October 2022

S. M. Meyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1598953

13 October 2022

M. M. Drake

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1598953

13 October 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

15 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1598953

full work available at URL

13 October 2022

https://api.elsevier.com/content/article/PII:S0002939414747865?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)74786-5

https://api.elsevier.com/content/article/PII:S0002939414747865?httpAccept=text/plain

13 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)74786-5

American Journal of Ophthalmology

13 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

632-637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

Vernal keratoconjunctivitis

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2974786-5

Ocular allergy and mast cell stabilizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2974786-5

Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2974786-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1598953%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference